Advertisement

Role of subcutaneous implantable loop recorder for the diagnosis of arrhythmias in Brugada syndrome: A United Kingdom single-center experience

Published:September 03, 2021DOI:https://doi.org/10.1016/j.hrthm.2021.08.034

      Background

      Experience with implantable loop recorders (ILRs) in Brugada syndrome (BrS) is limited.

      Objective

      The purpose of this study was to evaluate the indications and yield of ILR monitoring in a single-center BrS registry.

      Methods

      Demographic, clinical and follow-up data of BrS patients with ILR were collected.

      Results

      Of 415 BrS patients recruited consecutively, 50 (12%) received an ILR (58% male). Mean age at ILR implantation was 44 ± 15 years. Thirty-one (62%) had experienced syncopal or presyncopal episodes, and 23 (46%) had palpitations. During median follow-up of 28 months (range 1–68), actionable events were detected in 11 subjects (22%); 7 had recurrences of syncope/presyncope, with 4 showing defects in sinus node function or atrioventricular conduction. New supraventricular tachyarrhythmias were recorded in 6 subjects; a run of fast nonsustained ventricular tachycardia was detected in 1 patient. Patients implanted with an ILR were less likely to show a spontaneous type 1 pattern or depolarization electrocardiographic (ECG) abnormalities compared to those receiving a primary prevention implantable-cardioverter defibrillator. Age at implantation, gender, Shanghai score, and ECG parameters did not differ between subjects with and those without actionable events. ILR-related complications occurred in 3 cases (6%).

      Conclusion

      In a large cohort of BrS patients, continuous ILR monitoring yielded a diagnosis of tachy- or bradyarrhythmic episodes in 22% of cases. Recurrences of syncope were associated with bradyarrhythmic events. Use of ILR can be helpful in guiding the management of low-/intermediate-risk BrS patients and ascertaining the cause of unexplained syncope.

      Graphical abstract

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Priori S.G.
        • Wilde A.A.
        • Horie M.
        • et al.
        HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.
        Heart Rhythm. 2013; 10: 1932-1963
        • Priori S.G.
        • Blomstrom-Lundqvist C.
        • Mazzanti A.
        • et al.
        2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).
        Eur Heart J. 2015; 36: 2793-2867
        • Probst V.
        • Veltmann C.
        • Eckardt L.
        • et al.
        Long-term prognosis of patients diagnosed with Brugada syndrome: results from the Finger Brugada Syndrome Registry.
        Circulation. 2010; 121: 635-643
        • Sroubek J.
        • Probst V.
        • Mazzanti A.
        • et al.
        Programmed ventricular stimulation for risk stratification in the Brugada syndrome: a pooled analysis.
        Circulation. 2016; 133: 622-630
        • Vitali F.
        • Brieda A.
        • Balla C.
        • et al.
        Standard ECG in Brugada syndrome as a marker of prognosis: from risk stratification to pathophysiological insights.
        J Am Heart Assoc. 2021; 10e020767
        • Olde Nordkamp L.R.A.
        • Vink A.S.
        • Wilde A.A.M.
        • et al.
        Syncope in Brugada syndrome: prevalence, clinical significance, and clues from history taking to distinguish arrhythmic from nonarrhythmic causes.
        Heart Rhythm. 2015; 12: 367-375
        • Sacher F.
        • Arsac F.
        • Wilton S.B.
        • et al.
        Syncope in Brugada syndrome patients: prevalence, characteristics, and outcome.
        Heart Rhythm. 2012; 9: 1272-1279
        • Giustetto C.
        • Cerrato N.
        • Ruffino E.
        • et al.
        Etiological diagnosis, prognostic significance and role of electrophysiological study in patients with Brugada ECG and syncope.
        Int J Cardiol. 2017; 241: 188-193
        • Morita H.
        • Kusano-Fukushima K.
        • Nagase S.
        • et al.
        Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome.
        J Am Coll Cardiol. 2002; 40: 1437-1444
        • Giustetto C.
        • Cerrato N.
        • Gribaudo E.
        • et al.
        Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis.
        Heart Rhythm. 2014; 11: 259-265
        • Brignole M.
        • Moya A.
        • De Lange F.J.
        • et al.
        2018 ESC guidelines for the diagnosis and management of syncope.
        Eur Heart J. 2018; 39: 1883-1948
        • Brignole M.
        • Vardas P.
        • Hoffman E.
        • et al.
        Indications for the use of diagnostic implantable and external ECG loop recorders.
        Europace. 2009; 11: 671-687
        • Kubala M.
        • Assou L.
        • Traull S.
        • Gugenheim A.L.
        • Hermida J.S.
        Use of implantable loop recorders in patients with Brugada syndrome and suspected risk of ventricular arrhythmia.
        Europace. 2012; 14: 898-902
        • Sakhi R.
        • Assaf A.
        • Theuns D.A.M.J.
        • et al.
        Outcome of insertable cardiac monitors in symptomatic patients with Brugada syndrome at low risk of sudden cardiac death.
        Cardiology. 2020; 145: 413-420
        • Macfarlane P.W.
        • Devine B.
        • Clark E.
        The University of Glasgow (Uni-G) ECG analysis program.
        Comput Cardiol. 2005; 32: 451-454
        • MacFarlane P.W.
        • Antzelevitch C.
        • Haissaguerre M.
        • et al.
        The early repolarization pattern: a consensus paper.
        J Am Coll Cardiol. 2015; 66: 470-477
        • Antzelevitch C.
        • Yan G.X.
        • Ackerman M.J.
        • et al.
        J-wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge.
        Europace. 2017; 19: 665-694
        • Diederichsen S.Z.
        • Haugan K.J.
        • Højberg S.
        • et al.
        Complications after implantation of a new-generation insertable cardiac monitor: results from the LOOP study.
        Int J Cardiol. 2017; 241: 229-234
        • Maines M.
        • Zorzi A.
        • Tomasi G.
        • et al.
        Clinical impact, safety, and accuracy of the remotely monitored implantable loop recorder Medtronic Reveal LINQ TM.
        Europace. 2018; 20: 1050-1057
        • Mascia G.
        • Della Bona R.
        • Ameri P.
        • Canepa M.
        • Porto I.
        • Brignole M.
        Brugada syndrome and syncope: a systematic review.
        J Cardiovasc Electrophysiol. 2020; 31: 3334-3338
        • Take Y.
        • Morita H.
        • Wu J.
        • et al.
        Spontaneous electrocardiogram alterations predict ventricular fibrillation in Brugada syndrome.
        Heart Rhythm. 2011; 8: 1014-1021
        • Krahn A.D.
        • Klein G.J.
        • Yee R.
        • Takle-Newhouse T.
        • Norris C.
        Use of an extended monitoring strategy in patients with problematic syncope.
        Circulation. 1999; 99: 406-410
        • Cerrato N.
        • Giustetto C.
        • Gribaudo E.
        • et al.
        Prevalence of type 1 Brugada electrocardiographic pattern evaluated by twelve-lead twenty-four-hour Holter monitoring.
        Am J Cardiol. 2015; 115: 52-56
        • Gray B.
        • Kirby A.
        • Kabunga P.
        • et al.
        Twelve-lead ambulatory electrocardiographic monitoring in Brugada syndrome: potential diagnostic and prognostic implications.
        Heart Rhythm. 2017; 14: 866-874
        • Brugada P.
        • Brugada J.
        Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report.
        J Am Coll Cardiol. 1992; 20: 1391-1396
        • Maury P.
        • Rollin A.
        • Sacher F.
        • et al.
        Prevalence and prognostic role of various conduction disturbances in patients with the Brugada syndrome.
        Am J Cardiol. 2013; 112: 1384-1389
        • Smits J.P.P.
        • Eckardt L.
        • Probst V.
        • et al.
        Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients.
        J Am Coll Cardiol. 2002; 40: 350-356
        • Meregalli P.G.
        • Tan H.L.
        • Probst V.
        • et al.
        Type of SCN5A mutation determines clinical severity and degree of conduction slowing in loss-of-function sodium channelopathies.
        Heart Rhythm. 2009; 6: 341-348
        • Wilde A.A.M.
        • Amin A.S.
        Clinical spectrum of SCN5A mutations: long QT syndrome, Brugada syndrome, and cardiomyopathy.
        JACC Clin Electrophysiol. 2018; 4: 569-579
        • Havakuk O.
        • Viskin D.
        • Viskin S.
        • et al.
        Clinical presentation of sustained monomorphic ventricular tachycardia without cardiac arrest.
        J Am Heart Assoc. 2020; 9e016673
        • Olde Nordkamp L.R.A.
        • Postema P.G.
        • Knops R.E.
        • et al.
        Implantable cardioverter-defibrillator harm in young patients with inherited arrhythmia syndromes: a systematic review and meta-analysis of inappropriate shocks and complications.
        Heart Rhythm. 2016; 13: 443-454